Screening for critical congenital heart disease: advancing detection in the newborn

Elizabeth A Bradshaw1, Gerard R Martin

  • 1Children's National Medical Center, George Washington University School of Medicine, Washington, District of Columbia 20010, USA. ebradsha@childrensnational.org

Insights

Screening for critical congenital heart disease (CCHD) using pulse oximetry is now recommended. This cost-effective screening is easily implemented in hospitals and improves detection rates for newborns.

Area of Science:

  • Neonatal health
  • Public health screening
  • Congenital disease detection

Background:

  • Critical congenital heart disease (CCHD) screening via pulse oximetry was added to the uniform screening panel in 2011.
  • Professional organizations endorse CCHD screening, providing implementation guidance.

Purpose of the Study:

  • To review the implementation and effectiveness of CCHD screening.
  • To assess readiness and cost-effectiveness of CCHD screening protocols.

Main Methods:

  • Review of professional endorsements and implementation strategies.
  • Analysis of hospital readiness and cost-effectiveness data.

Main Results:

  • CCHD screening is endorsed by major pediatric and cardiology organizations.
  • Screening is cost-effective, requires no additional staff, and improves detection.
  • Hospitals generally possess necessary equipment, but CCHD may be missed in neonatal care units.

Conclusions:

  • CCHD screening is easily implemented in community hospitals.
  • The screening is cost-effective and feasible for many healthcare settings.
  • Some states are well-prepared for CCHD screening implementation.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...